Elisabetta Zampogna
- Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysisBy Giovanni Sotgiu, Rosella Centis, Lia D'Ambrosio, Jan-William C. Alffenaar, Holly A. Anger, Jose A. Caminero, Paolo Castiglia, Saverio De Lorenzo, Giovanni Ferrara, Won-Jung Koh, Giesela F. Schecter, Tae S. Shim, Rupak Singla, Alena Skrahina, Antonio Spanevello, Zarir F. Udwadia, Miquel Villar, Elisabetta Zampogna, Jean-Pierre Zellweger, Alimuddin Zumla and Giovanni Battista MiglioriGiovanni SotgiuFor a full list of affiliations details please see the Acknowledgements sectionRosella CentisFor a full list of affiliations details please see the Acknowledgements sectionLia D'AmbrosioFor a full list of affiliations details please see the Acknowledgements sectionJan-William C. AlffenaarFor a full list of affiliations details please see the Acknowledgements sectionHolly A. AngerFor a full list of affiliations details please see the Acknowledgements sectionJose A. CamineroFor a full list of affiliations details please see the Acknowledgements sectionPaolo CastigliaFor a full list of affiliations details please see the Acknowledgements sectionSaverio De LorenzoFor a full list of affiliations details please see the Acknowledgements sectionGiovanni FerraraFor a full list of affiliations details please see the Acknowledgements sectionWon-Jung KohFor a full list of affiliations details please see the Acknowledgements sectionGiesela F. SchecterFor a full list of affiliations details please see the Acknowledgements sectionTae S. ShimFor a full list of affiliations details please see the Acknowledgements sectionRupak SinglaFor a full list of affiliations details please see the Acknowledgements sectionAlena SkrahinaFor a full list of affiliations details please see the Acknowledgements sectionAntonio SpanevelloFor a full list of affiliations details please see the Acknowledgements sectionZarir F. UdwadiaFor a full list of affiliations details please see the Acknowledgements sectionMiquel VillarFor a full list of affiliations details please see the Acknowledgements sectionElisabetta ZampognaFor a full list of affiliations details please see the Acknowledgements sectionJean-Pierre ZellwegerFor a full list of affiliations details please see the Acknowledgements sectionAlimuddin ZumlaFor a full list of affiliations details please see the Acknowledgements sectionGiovanni Battista MiglioriFor a full list of affiliations details please see the Acknowledgements section
- Safety, tolerability and efficacy of linezolid for the treatment of M/XDR-TB: A systematic review and meta-analysisBy Giovanni Sotgiu, Holly Anger, Rosella Centis, Lia D'Ambrsoio, Saverio De Lorenzo, Christoph Lange, Gisela F. Schecter, Tae Sun Shim, Alena Skrahina, Miguel Villar, Elisabetta Zampogna, Jean-Pierre Zellweger and Giovanni Battista MiglioriGiovanni Sotgiu1Department of Biomedical Sciences, University of Sassari, Sassari, ItalyHolly Anger2Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, United StatesRosella Centis3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyLia D'Ambrsoio3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalySaverio De Lorenzo4Reference Hospital for MDR and HIV TB, E. Morelli Hospital, Sondalo, ItalyChristoph Lange5Div. of Clinical Infectious Diseases, Research Center Borstel, Borstel, GermanyGisela F. Schecter6Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, CA, United StatesTae Sun Shim7Division of Pulmonary & Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, KoreaAlena Skrahina8Clinical Department, National Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusMiguel Villar9Centre of Venda Nova, General Directorate of Health in Lisbon and Lung Diseases, Amadora, PortugalElisabetta Zampogna3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyJean-Pierre Zellweger10TB Clinic, Dept of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, SwitzerlandGiovanni Battista Migliori3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- Length of hospitalization for CPAP adaption in OSAS: Effects on complianceBy Elisabetta Zampogna, Cristina Facchetti, Anna Maria Lucioni, Eleonora Milani, Sabrina Della Patrona, Andrea Zanini and Antonio SpanevelloElisabetta Zampogna1Division of Pneumology, Salvatore Maugeri Foundation, IRCCS Rehabilitation Institute, Tradate, Varese, ItalyCristina Facchetti1Division of Pneumology, Salvatore Maugeri Foundation, IRCCS Rehabilitation Institute, Tradate, Varese, ItalyAnna Maria Lucioni1Division of Pneumology, Salvatore Maugeri Foundation, IRCCS Rehabilitation Institute, Tradate, Varese, ItalyEleonora Milani3Division of Cardiology, Salvatore Maugeri Foundation, IRCCS Rehabilitation Institute, Tradate, Varese, ItalySabrina Della Patrona1Division of Pneumology, Salvatore Maugeri Foundation, IRCCS Rehabilitation Institute, Tradate, Varese, ItalyAndrea Zanini5Department of Respiratory Disease, University of Insubria, Varese, ItalyAntonio Spanevello5Department of Respiratory Disease, University of Insubria, Varese, Italy
- Estimation of minimum clinically important difference in EQ-VAS score after pulmonary rehabilitation in COPD patientsBy Sabrina Della Patrona, Andrea Zanini, Marina Aiello, Daniela Adamo, Silvia Casale, Francesca Cherubino, Eleonora Raimondi, Elisabetta Zampogna, Alfredo Chetta and Antonio SpanevelloSabrina Della Patrona1Division of Pneumology, IRCCS Rehabilitation Institute of Tradate, Salvatore Maugeri Foundation, Tradate, Varese, ItalyAndrea Zanini1Division of Pneumology, IRCCS Rehabilitation Institute of Tradate, Salvatore Maugeri Foundation, Tradate, Varese, Italy2Department of Clinical and Experimental Medicine, University of Insubria, Varese, ItalyMarina Aiello3Respiratory Disease and Lung Function Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, ItalyDaniela Adamo1Division of Pneumology, IRCCS Rehabilitation Institute of Tradate, Salvatore Maugeri Foundation, Tradate, Varese, ItalySilvia Casale1Division of Pneumology, IRCCS Rehabilitation Institute of Tradate, Salvatore Maugeri Foundation, Tradate, Varese, ItalyFrancesca Cherubino1Division of Pneumology, IRCCS Rehabilitation Institute of Tradate, Salvatore Maugeri Foundation, Tradate, Varese, ItalyEleonora Raimondi1Division of Pneumology, IRCCS Rehabilitation Institute of Tradate, Salvatore Maugeri Foundation, Tradate, Varese, ItalyElisabetta Zampogna1Division of Pneumology, IRCCS Rehabilitation Institute of Tradate, Salvatore Maugeri Foundation, Tradate, Varese, ItalyAlfredo Chetta3Respiratory Disease and Lung Function Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, ItalyAntonio Spanevello1Division of Pneumology, IRCCS Rehabilitation Institute of Tradate, Salvatore Maugeri Foundation, Tradate, Varese, Italy2Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.